Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
3,883,034
-
Shares change
-
+154,445
-
Total reported value, excl. options
-
$16,963,807
-
Value change
-
+$659,798
-
Put/Call ratio
-
9.42%
-
Number of buys
-
24
-
Number of sells
-
-9
-
Price
-
$4.37
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2017
53 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2017.
XBiotech Inc. - Common Shares, no par value (XBIT) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,883,034 shares
of 33,289,095 outstanding shares and own 11.66% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,471,773 shares), VANGUARD GROUP INC (810,974 shares), STATE STREET CORP (310,900 shares), NORTHERN TRUST CORP (238,733 shares), GEODE CAPITAL MANAGEMENT, LLC (169,749 shares), SCHWAB CHARLES INVESTMENT MANAGEMENT INC (81,830 shares), CREDIT SUISSE AG/ (76,697 shares), Bank of New York Mellon Corp (73,322 shares), GROUP ONE TRADING, L.P. (48,971 shares), and GOLDMAN SACHS GROUP INC (46,308 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.